SCHEMBL492534

SCHEMBL492534

CN(C)C(c1ccc(F)cc1)C1CCC(NC(=O)COCCN(C)S(=O)(=O)c2ccc(Cl)cc2Cl)CC1

nearest known ligand 0.37

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.37
SMN1; SMN2 Q16637 3/20 0.37
MAPT P10636 2/20 0.37
TRPV4 Q9HBA0 2/20 0.36
BDKRB1 P46663 2/20 0.36
NPC1 O15118 3/20 0.35
RAB9A P51151 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
EPHX2 P34913 1/20 0.35
POLB P06746 1/20 0.34
ALDH1A1 P00352 1/20 0.34
ATF4 P18848 1/20 0.34
HPGD P15428 1/20 0.34
MEN1 O00255 1/20 0.34
NPY1R P25929 1/20 0.34
NPY2R P49146 1/20 0.34
KMT2A Q03164 1/20 0.34
GAA P10253 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL492458 0.92 MAPT (0.38) LMNASMN1; SMN2MAPTTRPV4BDKRB1
SCHEMBL493973 0.92 OPRL1 (0.37) MAPTTRPV4BDKRB1NPC1RAB9A
SCHEMBL492948 0.91 LMNA (0.37) LMNASMN1; SMN2MAPTBDKRB1NPC1
SCHEMBL493003 0.89 TRPV4 (0.36) TRPV4BDKRB1HPGD
SCHEMBL493268 0.89 LMNA (0.38) LMNASMN1; SMN2MAPTPOLBALDH1A1
SCHEMBL492842 0.88 BDKRB1 (0.36) TRPV4BDKRB1
SCHEMBL493560 0.86 BDKRB1 (0.40) LMNASMN1; SMN2BDKRB1NPC1RAB9A
SCHEMBL492945 0.86 LMNA (0.41) LMNASMN1; SMN2POLBALDH1A1MEN1
SCHEMBL493359 0.84 BDKRB1 (0.36) LMNATRPV4BDKRB1ALDH1A1
SCHEMBL493575 0.83 BDKRB1 (0.41) LMNAMAPTBDKRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US claimed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP claimed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US claimed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO claimed
US-8106055-B2 Substituted amide compounds GRUENENTHAL GMBH (DE) 2012-01-31 US disclosed
EP-2139851-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2010-01-06 EP disclosed
US-20080306084-A1 Substituted Amide Compounds GRUENENTHAL GMBH (DE) 2008-12-11 US disclosed
WO-2008131946-A2 SUBSTITUTED AMIDE DERIVATIVES Grünenthal GmbH (DE) 2008-11-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080306084-A1 Substituted Amide Compounds OPRK1, NAA50, ACMSD LMNA 2485/4885SMN1; SMN2 1729/4885MAPT 1653/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.